Charles Sternberg, Associate Editor07.14.22
Glooko AB has announced, in partnership with the Diabetes Technology Network (DTN)/ Association of British Clinical Diabetologists (ABCD), the expansion of Academy, its online medical education program for clinicians who treat people with diabetes, into Ireland.
Originally inspired after discussions with the National Health Service England (NHSE) as part of its effort to ensure all healthcare professionals learn uniformly about technology, the program will help clinicians further increase their knowledge and stay current on the ever-growing assortment of new diabetes technologies.
Academy focuses exclusively on diabetes health technology and education. The program includes an extensive range of online courses for healthcare providers (HCPs) to increase expertise and mastery of these technologies, to help deploy them to people with diabetes. All courses are accessed through the Glooko platform or the ABCD website.
Ireland is the second country to implement Academy in Glooko’s plans to provide the program globally. Since launching in the UK in October of 2020, over 1,000 clinicians across more than 300 clinics have registered for the program, with more than 750 Continuing Professional Development (CPD) certificates awarded.
“We are extremely pleased with the successful adoption of Academy in the UK,” said Russ Johannesson, CEO of Glooko. “We are particularly excited to continue our expansion and offer the programme in Ireland. Our goal is to not only equip primary care and specialist HCPs with the technological skill set relevant to their professional development, but to also support them in building a wider range of capabilities, as treating chronic conditions moves increasingly towards a more digital world.”
The program is available to all diabetes healthcare professionals in Ireland at no cost and was funded in part via sponsorships from global industry partners like AgaMatrix, Dexcom, Lilly, mylife Diabetescare, Novo Nordisk and Roche. Production was provided by DigiBete (DigiBete Global, Leeds, UK), which remains actively involved in Academy. The curriculum covers the majority of the diabetes devices and technologies, and HCPs that complete the program will receive CPD accreditation as well as DTN UK/ABCD certification.
Academy is part of Glooko’s global mission to enhance the lives of people with chronic conditions by connecting them with their HCPs and equipping both with the tools needed to achieve improved outcomes.
Originally inspired after discussions with the National Health Service England (NHSE) as part of its effort to ensure all healthcare professionals learn uniformly about technology, the program will help clinicians further increase their knowledge and stay current on the ever-growing assortment of new diabetes technologies.
Diabetes Health Technology & Education
According to the International Diabetes Federation, Ireland, with a population of just five million people, is ranked 7th in the world for diabetes-related health expenditure per person. For people with diabetes and their healthcare providers, managing the myriad technologies like glucose monitors and insulin pumps, and the data volumes accompanying these technologies, is a well-established challenge. Technology tools like web-based programs, telehealth, mobile apps and remote monitoring are improving users’ accessibility and connectivity, but adoption of these innovations can be slow and complicated.Academy focuses exclusively on diabetes health technology and education. The program includes an extensive range of online courses for healthcare providers (HCPs) to increase expertise and mastery of these technologies, to help deploy them to people with diabetes. All courses are accessed through the Glooko platform or the ABCD website.
Ireland is the second country to implement Academy in Glooko’s plans to provide the program globally. Since launching in the UK in October of 2020, over 1,000 clinicians across more than 300 clinics have registered for the program, with more than 750 Continuing Professional Development (CPD) certificates awarded.
“We are extremely pleased with the successful adoption of Academy in the UK,” said Russ Johannesson, CEO of Glooko. “We are particularly excited to continue our expansion and offer the programme in Ireland. Our goal is to not only equip primary care and specialist HCPs with the technological skill set relevant to their professional development, but to also support them in building a wider range of capabilities, as treating chronic conditions moves increasingly towards a more digital world.”
The program is available to all diabetes healthcare professionals in Ireland at no cost and was funded in part via sponsorships from global industry partners like AgaMatrix, Dexcom, Lilly, mylife Diabetescare, Novo Nordisk and Roche. Production was provided by DigiBete (DigiBete Global, Leeds, UK), which remains actively involved in Academy. The curriculum covers the majority of the diabetes devices and technologies, and HCPs that complete the program will receive CPD accreditation as well as DTN UK/ABCD certification.
Academy is part of Glooko’s global mission to enhance the lives of people with chronic conditions by connecting them with their HCPs and equipping both with the tools needed to achieve improved outcomes.
